Efficacy and Safety Study of CD 2027 Spray in Subjects With Plaque-type Psoriasis

Summary

This was a multicenter, randomized, vehicle-controlled, double-blind parallel group study to evaluate the efficacy and safety of CD 2027 Oily Spray applied twice daily for 8 weeks in participants with plaque-type psoriasis.

Timeline

Start

2008-09

Primary completion

2009-01

Completion

2009-03

Drugs

Indications